三、淋巴组织间质源性肿瘤（7个实体/类型）下表中左侧边2022年第五版WHO-HAEM5分类（淋系），右侧为2017年第四版修订WHO-HAEM4R分类（淋系）。注：lymphoproliferative disorder（LPD），淋巴（组织）增生性疾病，淋巴（组织）增殖性疾病。B细胞淋巴增殖性疾病和肿瘤 B-cell lymphoid proliferations and lymphomas ...
【参考文献】 [1] Alaggio, R., Amador, C., Anagnostopoulos, I. et al. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms. Leukemia 36, 1720–1748 (2022). https://doi.org/...
参考文献: Alaggio, Rita et al. “The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms.” Leukemia vol. 36,7 (2022): 1720-1748. doi:10.1038/s41375-022-01620-2.
在骨髓形态正常的一部分患者中检测到相关基因突变,提示骨髓中也存在低水平的克隆性骨髓疾病或CH。 信源:Khoury, J.D., Solary, E., Abla, O. et al. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid...
Commentary on the 2022 WHO Classification of Haematolymphoid Tumours: Myeloid and histiocytic/dendritic neoplasmsdoi:10.1038/s41375-025-02544-3Robert Peter Galehttps://ror.org/041kmwe10grid.7445.20000 0001 2113 8111Centre for HaematologyImperial College of Science, Technology and Medicine London UK...
[1] Alaggio, R., Amador, C., Anagnostopoulos, I. et al. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms. Leukemia 36, 1720–1748 (2022). https://doi.org/10.1038/s41375-022-01620-2 ...
2022年第5版WHO造血淋巴肿瘤分类(5th edition of the WHO Classification ofHaematolymphoid Tumours,WHO-HAEM5),与2017年WHO第4修订版造血和淋巴组织肿瘤分类淋巴瘤部分相比,首次引入瘤样病变(tumour-likelesions)概念,结合分子生物学进一步细化了淋巴瘤分类。
The new approach in the 5th edition worked quite well across all blue books completed thus far. The only problem area was the classification of haematolymphoid tumours, which had previously used an ad-hoc ‘clinical advisory committee’ (CAC). Unfortunately, despite the fact that the CAC was ...
Family renamed myeloid/lymphoid neoplasms with eosinophilia and tyrosine kinase gene fusions (MLN-TK). Recognition of novel types with JAK2 rearrangements, FLT3 rearrangements, and ETV6::ABL1 fusion. New scalable genetic framework introduced under MLN-TK with other defined tyrosine kinase fusions. Acute...
Two review articles summarizing the fifth edition of the World Health Organization (WHO) classification of haematolymphoid tumours were officially published on Leukemia journal in 2022. This article briefly summarizes some important advances and changes in the fifth edition of WHO classification of haemato...